The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Novo Nordisk A/S

NYSE: NVO
Last

(U.S.) $56.34

Today's change+0.05 +0.09%
Updated July 27 4:02 PM EDT. Delayed by at least 15 minutes.
 

Novo Nordisk A/S

NYSE: NVO
Last

(U.S.) $56.34

Today's change+0.05 +0.09%
Updated July 27 4:02 PM EDT. Delayed by at least 15 minutes.

Novo Nordisk A/S up slightly

Novo Nordisk A/S closed up just (U.S.)$0.05 Wednesday to (U.S.)$56.34. Over the last five days, shares have gained 1.88%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 7.04% during the last year.

Key company metrics

  • Open(U.S.) $55.85
  • Previous close(U.S.) $56.29
  • High(U.S.) $56.41
  • Low(U.S.) $55.83
  • Bid / Ask(U.S.) $55.00 / (U.S.) $56.50
  • YTD % change-3.00%
  • Volume1,460,974
  • Average volume (10-day)940,538
  • Average volume (1-month)1,273,119
  • Average volume (3-month)1,262,389
  • 52-week range(U.S.) $46.17 to (U.S.) $60.34
  • Beta0.78
  • Trailing P/E28.39×
  • P/E 1 year forward24.93×
  • Forward PEG2.03×
  • Indicated annual dividend(U.S.) $0.96
  • Dividend yield1.70%
  • Trailing EPS(U.S.) $1.98
Updated July 27 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+31.33%

Based on its net profit margin of 31.33%, Novo Nordisk A/S is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.02%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue27,21228,87626,79227,059
Total other revenue--------
Total revenue27,21228,87626,79227,059
Gross profit22,97824,26822,94523,200
Total cost of revenue4,2344,6083,8473,859
Total operating expense14,90317,75114,81214,577
Selling / general / administrative7,6499,2037,9038,062
Research & development3,3044,0343,2893,035
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total-284-94-227-379
Operating income12,30911,12511,98012,482
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax11,95310,31410,13610,548
Income after tax9,4558,2588,3838,343
Income tax, total2,4982,0561,7532,205
Net income9,4558,2588,3838,343
Total adjustments to net income--------
Net income before extra. items9,4558,2588,3838,343
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9,4558,2588,3838,343
Inc. avail. to common incl. extra. items9,4558,2588,3838,343
Diluted net income9,4558,2588,3848,343
Dilution adjustment0--1--
Diluted weighted average shares2,5502,5512,5722,584
Diluted EPS excluding extraordinary itemsvalue per share3.713.243.263.23
Dividends per sharevalue per share0.006.400.000.00
Diluted normalized EPSvalue per share3.713.243.263.23